![Douglas Ingram](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Ingram
Director/Board Member at
RELAY THERAPEUTICS, INC.
Net worth: 14 M $ as of 2026-08-30
Profile
Douglas S. Ingram occupies the position of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. He is also on the board of Allergan Foundation and Relay Therapeutics, Inc. He previously held the position of Attorney at Gibson, Dunn & Crutcher LLP, Chief Executive Officer & Director at Chase Pharmaceuticals Corp. and President for Allergan, Inc. Mr. Ingram received an undergraduate degree from Arizona State University and a graduate degree from the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-07 | 390,307 ( 0.37% ) | 8 M $ | 2026-08-30 | |
| 2026-01-14 | 59,016 ( 0.04% ) | 5 M $ | 2026-08-30 | |
| 2026-06-08 | 25,000 ( 0.01% ) | 459 500 $ | 2026-08-30 |
Latest news about Douglas Ingram
Douglas Ingram active positions
| Companies | Position | Start |
|---|---|---|
| RELAY THERAPEUTICS, INC. | Director/Board Member | 2019-05-31 |
Allergan Foundation
 Allergan Foundation Medical/Nursing ServicesHealth Services The Allergan Foundation, operating under AbbVie, provides information and support related to Botox® (onabotulinumtoxinA), a prescription treatment for severe primary axillary hyperhidrosis (severe underarm sweating) in adults when topical medicines are insufficient. The non-profit company is based in Irvine, CA. Botox® is administered by medical professionals and can offer relief for up to approximately seven months. The foundation details the clinical assessment process, important safety information, potential side effects, and the need for patients to disclose medical conditions and medications before treatment. AbbVie also offers patient support programs to assist with medication access and costs. | Director/Board Member | - |
Former positions of Douglas Ingram
| Companies | Position | End |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Executive Officer | 2026-07-27 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 2026-03-18 |
Pacific Mutual Holding Co.
 Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Director/Board Member | 2018-04-30 |
| SKYE BIOSCIENCE, INC. | Director/Board Member | 2018-01-18 |
| ENDO INTERNATIONAL PLC | Director/Board Member | 2017-11-05 |
Training of Douglas Ingram
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Gibson, Dunn & Crutcher, Inc.
 Gibson, Dunn & Crutcher, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Pacific Mutual Holding Co.
Pacific Mutual Holding Co. Insurance Brokers/ServicesFinance Provides insurance, financial and other investment services | Finance |
ECC Capital Corp.
 ECC Capital Corp. Real Estate Investment TrustsFinance Provides mortgage finance real estate investment trust services | Finance |
Volcom, Inc.
 Volcom, Inc. Apparel/FootwearConsumer Non-Durables Manufactures and distributes clothes and accessories | Consumer Non-Durables |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops novel medications for the treatment of Alzheimer’s disease | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Life Insurance Co.
 Pacific Life Insurance Co. Life/Health InsuranceFinance Provides life insurance products, annuities and mutual funds solutions | Finance |
Allergan Foundation
Allergan Foundation Medical/Nursing ServicesHealth Services The Allergan Foundation, operating under AbbVie, provides information and support related to Botox® (onabotulinumtoxinA), a prescription treatment for severe primary axillary hyperhidrosis (severe underarm sweating) in adults when topical medicines are insufficient. The non-profit company is based in Irvine, CA. Botox® is administered by medical professionals and can offer relief for up to approximately seven months. The foundation details the clinical assessment process, important safety information, potential side effects, and the need for patients to disclose medical conditions and medications before treatment. AbbVie also offers patient support programs to assist with medication access and costs. | Health Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
- Stock Market
- Insiders
- Douglas Ingram
